Trial record 1 of 11 for:    Immunovative
Previous Study | Return to List | Next Study

Study of AlloStim In-Situ Vaccine in Pre-Treated Metastatic Breast Cancer

This study has been withdrawn prior to enrollment.
(changing indication)
Sponsor:
Information provided by (Responsible Party):
Immunovative Therapies, Ltd.
ClinicalTrials.gov Identifier:
NCT01741038
First received: November 29, 2012
Last updated: April 1, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: July 2016
  Estimated Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)